Beth Gardner spent several years as a competitive rower and learned plenty of lessons along the way that helped her throughout her cancer experience. Here, she shares what those key lessons were and how they can help others with cancer.
2022 ASCO Annual Meeting Research Round Up: Advances in Treating Multiple Myeloma, Breast Cancer, and Cancer in People 60 and Older
In this podcast, members of the American Society of Clinical Oncology (ASCO) discuss new research presented at the 2022 ASCO Annual Meeting in multiple myeloma, breast cancer, and cancer in people age 60 or older.
Breast cancer survivor Karen Kratenstein shares helpful tips on what to say when talking with and supporting a loved one with cancer, as well as how other people with cancer can ask for the support they need.
In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer.
2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in People 55+ With Luminal A Breast Cancer
The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing.
2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing Sarcoma, and Multiple Myeloma
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.
2022 ASCO Annual Meeting: Targeted Therapy for Advanced HR-Positive, HER2-Negative Breast Cancer and Using Liquid Biopsy to Guide Treatment for Stage II Colon Cancer
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.
Reunión anual de la ASCO de 2022: Gasto en servicios sociales y supervivencia al cáncer, Concientización sobre ensayos clínicos en personas de raza negra con cáncer de mama, Equidad y telemedicina, y La supervivencia en el neuroblastoma
La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) de 2022 se llevará a cabo del 3 al 7 de junio. En esta publicación inicial de la investigación que se presenta en la reunión, los estudios examinan cómo la raza, el origen étnico, la pobreza y otros factores sociales y demográficos afectan la vida de las personas con cáncer.
2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical Trials Awareness Among Black People With Breast Cancer, Telemedicine Use During the Pandemic Is Not Equal, and Factors Affecting Survival in Neuroblastoma
The 2022 ASCO Annual Meeting is being held June 3 to 7. In this early release of research being presented at the meeting, studies examine how race, ethnicity, poverty, and other social and demographic factors affect the lives of people with cancer.
At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider.